Goodwill and Intangible Assets

12 Months Ended

Mar. 31, 2017

Goodwill and Intangible Assets Disclosure [Abstract]

Goodwill

The changes in the carrying amount of goodwill by segment are as follows:



(In millions)	Consumer Digital Safety		Enterprise Security			Total
Balance as of April 3, 2015	$	1,230	$	1,916		$	3,146
Translation adjustments	1		1			2
Balance as of April 1, 2016	1,231		1,917			3,148
Acquisition of Blue Coat	—		4,083			4,083
Acquisition of LifeLock	1,318		83			1,401
Translation adjustments	—		(5		)	(5		)
Balance as of March 31, 2017	$	2,549	$	6,078		$	8,627

Intangible assets, net



	March 31, 2017							April 1, 2016
(In millions)	Gross Carrying Amount		Accumulated Amortization			Net Carrying Amount		Gross Carrying Amount		Accumulated Amortization			Net Carrying Amount
Customer relationships	$	1,646	$	(322	)	$	1,324	$	406	$	(320	)	$	86
Developed technology	1,006		(229		)	777		144		(84		)	60
Finite-lived trade names	23		(6		)	17		2		(2		)	—
Patents	21		(20		)	1		21		(18		)	3
Other	2		—			2		—		—			—
Total finite-lived intangible assets	2,698		(577		)	2,121		573		(424		)	149
Indefinite-lived trade names	864		—			864		294		—			294
In-process research and development	19		—			19		—		—			—
Total	$	3,581	$	(577	)	$	3,004	$	867	$	(424	)	$	443

As a result of our acquisitions of Blue Coat and LifeLock, we recorded $1.6 billion and $1.2 billion of acquired intangible assets, respectively, during fiscal 2017. See Note 6 for more information on the Blue Coat and LifeLock acquisitions. As of March 31, 2017, future amortization expense related to intangible assets that have finite lives is as follows by fiscal year:



(In millions)	March 31, 2017
2018	$	452
2019	426
2020	407
2021	295
2022	235
Thereafter	306
Total	$	2,121

- Definition

The entire disclosure for the aggregate amount of goodwill and a description of intangible assets, which may include (a) for amortizable intangible assets (also referred to as finite-lived intangible assets), the carrying amount, the amount of any significant residual value, and the weighted-average amortization period, (b) for intangible assets not subject to amortization (also referred to as indefinite-lived intangible assets), the carrying amount, and (c) the amount of research and development assets acquired and written off in the period, including the line item in the income statement in which the amounts written off are aggregated, if not readily apparent from the income statement. Also discloses (a) for amortizable intangibles assets in total and by major class, the gross carrying amount and accumulated amortization, the total amortization expense for the period, and the estimated aggregate amortization expense for each of the five succeeding fiscal years, (b) for intangible assets not subject to amortization the carrying amount in total and by major class, and (c) for goodwill, in total and for each reportable segment, the changes in the carrying amount of goodwill during the period (including the aggregate amount of goodwill acquired, the aggregate amount of impairment losses recognized, and the amount of goodwill included in the gain (loss) on disposal of a reporting unit). If any part of goodwill has not been allocated to a reportable segment, discloses the unallocated amount and the reasons for not allocating. For each impairment loss recognized related to an intangible asset (excluding goodwill), discloses: (a) a description of the impaired intangible asset and the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method for determining fair value, (c) the caption in the income statement or the statement of activities in which the impairment loss is aggregated, and (d) the segment in which the impaired intangible asset is reported. For each goodwill impairment loss recognized, discloses: (a) a description of the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method of determining the fair value of the associated reporting unit, and (c) if a recognized impairment loss is an estimate not finalized and the reasons why the estimate is not final. May also disclose the nature and amount of any significant adjustments made to a previous estimate of an impairment loss.

+ References + Details